Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies41
The Flyover Coalition
The Flyover Coalition is an event management company supporting Flyover Country.
Sector
Subsector
Keywords
Location
Marketing Lancashire
Marketing Lancashire is a not-for-profit agency promoting Lancashire on a national and international stage.
Sector
Subsector
Location
Times Kim Woo
Pursue excellence, challenge the limit, be down-to-earth, and be grateful.
Sector
Subsector
Keywords
Location
NgVikings
ngVikings is a non-profit organization that organizes Angular conferences in Nordic countries.
Sector
Subsector
Location
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 27.03.2024. Their latest investor Forbion. Their latest round Series B
EQT Ventures
EQT Ventures is a European VC fund that provides support and advice to bold and ambitious founders.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
F-Prime Capital
F-Prime Capital is a venture capital firm that invests in technology, healthcare and life sciences sectors in the United States and Europe.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Forbion
Netherlands-based venture capital firm investing in life sciences and MedTech companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Norwest Venture Partners
Norwest is a global venture capital and growth equity investment firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors19
Number of lead investors
Number of investors
Forbion
Netherlands-based venture capital firm investing in life sciences and MedTech companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Jasper Bos
Jasper Bos, PhD is Director with Merck Serono Ventures, the corporate venture capital fund of Merck Serono SA, which invests in early stage and start-up biotech and pharmaceutical companies. Prior to joining Merck Serono SA, Jasper was instrumental in the founding of IFHA, a private equity fund backed by large Dutch and international institutional investors. He was instrumental in the structuring and capital raise of IFHA and negotiated and managed private equity investments in emerging economies in the healthcare and insurance sectors. Before IFHA, Jasper worked as health economics and strategy manager at the Netherlands Vaccine Institute. Currently, he is a Member of the Board of Directors of Prexton Therapeutics SA, EpiTherapeutics AS, Galecto Biotech, Neviah Genomics and an Observer to the Board of Vaximm AG. He holds a PhD in Pharmacy from the University of Groningen, the Netherlands and has published more than 30 articles on health economics and vaccines.
current job
Longwood Fund
Longwood Fund is a venture capital firm that invests in healthcare and life science companies, focusing on biotechnology and therapeutics.
Sector
Subsector
Location
count Of Investments
count Of Exists
F-Prime Capital
F-Prime Capital is a venture capital firm that invests in technology, healthcare and life sciences sectors in the United States and Europe.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Stacie Weninger
Stacie Weninger is the President of FBRI. Prior to this position, she was the Senior Director of Science Programs for the Fidelity Foundations. In 2005, Dr. Weninger served as the Project Manager and Senior Analyst for the Task Force on Women in Science at Harvard University. From 2001-2005, Dr. Weninger was a Senior Scientist at Cell Press for the journal Neuron. Before joining Cell Press, Dr. Weninger was a postdoctoral research fellow at Children’s Hospital Boston and Harvard Medical School with Dr. Bruce Yankner. She was a Howard Hughes Medical Institute predoctoral fellow in the Program in Neuroscience at Harvard University. While a graduate student and postdoctoral research fellow, Dr. Weninger was actively involved in undergraduate teaching, winning six teaching awards. Dr. Weninger received a Ph.D. in neuroscience from Harvard University, and a B.S. degree in chemistry with highest honors from the University of North Carolina, Chapel Hill. She currently chairs the Collaboration for Alzheimer’s Prevention; is President of Alzforum; serves as Chairman of the Board of Directors for Rugen Therapeutics; serves as a member of the Board of Directors for Enspectra, Aratome, Q-State Biosciences, Digital Cognition Technologies, and Target ALS; and she previously served as a founding member of the Board of Directors for Denali Therapeutics (NASDAQ: DNLI) as well as a member of the Board of Directors for Annexon Biosciences, BRI-Alzan (acquired by MeiraGTx), and Inscopix.
current job
